{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:16:55Z","timestamp":1791357415401,"version":"4.3.1"},"reference-count":16,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1001\/jamaneurol.2018.3077","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T13:47:53Z","timestamp":1539697673000},"page":"28","source":"Crossref","is-referenced-by-count":78,"title":["Effect of Gabapentin vs Pregabalin on Pain Intensity in Adults With Chronic Sciatica"],"prefix":"10.1001","volume":"76","author":[{"given":"Kelvin","family":"Robertson","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Medical Services Group, The Townsville Hospital, Douglas, Townsville, Queensland, Australia"},{"name":"College of Medicine and Dentistry, James Cook University, Douglas, Townsville, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence A. G.","family":"Marshman","sequence":"additional","affiliation":[{"name":"College of Medicine and Dentistry, James Cook University, Douglas, Townsville, Queensland, Australia."},{"name":"Department of Neurosurgery, Institute of Surgery, The Townsville Hospital, Douglas, Townsville, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Plummer","sequence":"additional","affiliation":[{"name":"Public Health & Topical Medicine, James Cook University, Douglas, Townsville, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Downs","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Institute of Surgery, The Townsville Hospital, Douglas, Townsville, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"22","key":"noi180068r1","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1097\/BRS.0b013e318183a4a2","article-title":"Sciatica: review of epidemiological studies and prevalence estimates.","volume":"33","author":"Konstantinou","year":"2008","journal-title":"Spine (Phila Pa 1976)"},{"issue":"e497","key":"noi180068r2","doi-asserted-by":"publisher","first-page":"e497","DOI":"10.1136\/bmj.e497","article-title":"Drugs for relief of pain in patients with sciatica: systematic review and meta-analysis.","volume":"344","author":"Pinto","year":"2012","journal-title":"BMJ"},{"issue":"442","key":"noi180068r3","first-page":"358","article-title":"Is chronic non-specific low back pain chronic? definitions of a problem and problems of a definition.","volume":"49","author":"Cedraschi","year":"1999","journal-title":"Br J Gen Pract"},{"issue":"11","key":"noi180068r4","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1093\/pm\/pnw052","article-title":"Gabapentin superadded to a pre-existent regime containing amytriptyline for chronic sciatica.","volume":"17","author":"Robertson","year":"2016","journal-title":"Pain Med"},{"issue":"e487","key":"noi180068r5","doi-asserted-by":"publisher","first-page":"e487","DOI":"10.1136\/bmj.e487","article-title":"Treating sciatica in the face of poor evidence.","volume":"344","author":"Chou","year":"2012","journal-title":"BMJ"},{"key":"noi180068r6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jocn.2015.05.061","article-title":"Pregabalin and gabapentin for the treatment of sciatica.","volume":"26","author":"Robertson","year":"2016","journal-title":"J Clin Neurosci"},{"issue":"12","key":"noi180068r7","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMoa1614292","article-title":"Trial of pregabalin for acute and chronic sciatica.","volume":"376","author":"Mathieson","year":"2017","journal-title":"N Engl J Med"},{"issue":"e7586","key":"noi180068r8","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"noi180068r9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13063-017-2400-y","article-title":"Pregabalin versus gabapentin in the treatment of sciatica: study protocol for a randomised, double-blind, cross-over trial (PAGPROS).","volume":"19","author":"Robertson","year":"2018","journal-title":"Trials"},{"issue":"3","key":"noi180068r13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations.","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"issue":"3","key":"noi180068r14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/emj.18.3.205","article-title":"The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain.","volume":"18","author":"Kelly","year":"2001","journal-title":"Emerg Med J"},{"issue":"4","key":"noi180068r15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.berh.2005.03.003","article-title":"Clinically important outcomes in low back pain.","volume":"19","author":"Ostelo","year":"2005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"noi180068r10","unstructured":"About eTG complete. Therapeutic Guidelines https:\/\/tgldcdp.tg.org.au\/index. Accessed September 5, 2018."},{"key":"noi180068r11","unstructured":"Australian Medicines Handbook 2014. https:\/\/www.bookdepository.com\/Australian-Medicines-Handbook-2014-Simone-Rossi\/9780987550125. Accessed September 5, 2018."},{"key":"noi180068r12","unstructured":"Neuropathic pain in adults: pharmacological management in non-specialist settings. National Institute for Health and Care Excellence. https:\/\/www.nice.org.uk\/guidance\/cg173. Accessed September 5, 2018."},{"key":"noi180068r16","unstructured":"Committee for Medicinal Products for Human Use. Guideline on Missing Data in Confirmatory Clinical Trials London: European Medicines Agency. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2010\/09\/WC500096793.pdf. Accessed September 5, 2018."}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2707478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T11:30:36Z","timestamp":1547465436000},"score":1,"resource":{"primary":{"URL":"http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2018.3077"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2019,1,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2018.3077","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734240789.793555562","asserted-by":"object"}]},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1,1]]}}}